Status:

TERMINATED

Photobiomodulation in the Treatment of Hand-foot Syndrome

Lead Sponsor:

University of Nove de Julho

Conditions:

Erythrodysesthesia Syndrome

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

A cytotoxic complication caused by chemotherapy is hand-foot syndrome, also known as palmar-plantar erythrodysesthesia (PPE). The mechanism is not yet clear, but it is thought that the chemotherapeuti...

Detailed Description

Methodology: randomized, controlled, double-blind, single-center clinical trial. The study population (40 participants) will be divided into two groups - Group 1: moisturizer plus LED (light emitting ...

Eligibility Criteria

Inclusion

  • over 18 years of age,
  • hospitalized or outpatients,
  • with oncological pathology (confirmed by anatomo-pathological or cytological diagnosis)
  • undergoing chemotherapy treatment (oral capecitabine and 5-Fluorouracil in continuous infusion, following the treatment plans protocolized by the institution: Xelox Bevacizumab, Capecitabine, Capecitabine + Radiotherapy, Folfoxiri, Xeliri-Bevacizumab, Folfox4-Bevacizumab , Docetaxel-CDDP-5-Fluorouracil (Colony Stimulating Factors), mFolfirinox q/14 days, Flot.)
  • who develop hand-foot syndrome of greater or equal toxicity to 1 on the CTC scale NCI v. 5.0 and on Saif scale. Et al. for dark skin

Exclusion

  • Patients with palmo-plantar skin comorbidities,
  • autoimmune comorbidities,
  • amputated limbs,
  • systemic infection,
  • localized or regional limb infection,
  • respiratory isolation,
  • contact isolation
  • insulin-requiring diabetics.

Key Trial Info

Start Date :

March 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2024

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT05337423

Start Date

March 1 2023

End Date

June 30 2024

Last Update

August 27 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Centro de Asistencia del Sindicato Médico del Uruguay

Montevideo, Uruguay, 11600

2

Instituto Nacional del Cáncer

Montevideo, Uruguay, 11600

Photobiomodulation in the Treatment of Hand-foot Syndrome | DecenTrialz